We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.84%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.5B
AUM Growth
-$1.93B
(-10%)
Cap. Flow
-$2.26B
Cap. Flow
% of AUM
-13.67%
Top 10 Holdings %
Top 10 Hldgs %
16.19%
Holding
1,547
New
416
Increased
366
Reduced
319
Closed
426
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$233M |
| 2 |
TSMC
TSM
|
+$222M |
| 3 |
Philip Morris
PM
|
+$189M |
| 4 |
Qualcomm
QCOM
|
+$171M |
| 5 |
AstraZeneca
AZN
|
+$127M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$396M |
| 2 |
Citigroup
C
|
+$269M |
| 3 |
Cisco
CSCO
|
+$253M |
| 4 |
Boeing
BA
|
+$166M |
| 5 |
Bank of America
BAC
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.96% |
| 2 | Technology | 21.61% |
| 3 | Consumer Staples | 8.79% |
| 4 | Communication Services | 8.54% |
| 5 | Financials | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Avista
AVA
$3.24B
| $1.82M | 0.01% |
+59,556
| New | +$1.73M |
|
|
SGNT
677
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.82M | 0.01% |
77,926
+19,733
| +34% | +$432K |
|
678
Harte-Hanks
HHS
| $1.81M | 0.01% |
20,442
-8,372
| -29% | -$652K |
|
679
Verisk Analytics
VRSK
$25B
| $1.8M | 0.01% |
+30,025
| New | +$1.9M |
|
|
OPLK
680
DELISTED
OPLINK COMMUNICATIONS INC
OPLK
| $1.78M | 0.01% |
99,323
-3,613
| -4% | -$64.1K |
|
|
ENLC
681
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $1.78M | 0.01% |
+52,536
| New | +$1.95M |
|
|
KWK
682
DELISTED
QUICKSILVER RESOURCES INC
KWK
| $1.78M | 0.01% |
+677,486
| New | +$2.07M |
|
683
NatWest
NWG
$76.4B
| $1.78M | 0.01% |
159,346
+148,587
| +1,381% | +$1.78M |
|
684
Ambev
ABEV
$46.4B
| $1.78M | 0.01% |
+239,889
| New | +$1.68M |
|
|
SN
685
DELISTED
Sanchez Energy Corporation
SN
| $1.78M | 0.01% |
+59,947
| New | +$1.67M |
|
|
RT
686
DELISTED
Ruby Tuesday Georgia
RT
| $1.77M | 0.01% |
315,954
+183,343
| +138% | +$1.05M |
|
687
Prospect Capital
PSEC
$1.17B
| $1.77M | 0.01% |
163,584
-335,634
| -67% | -$3.71M |
|
|
TESO
688
DELISTED
Tesco Corp
TESO
| $1.77M | 0.01% |
+95,488
| New | +$1.86M |
|
|
CZR
689
DELISTED
Caesars Entertainment Corporation
CZR
| $1.75M | 0.01% |
92,082
-76,287
| -45% | -$1.76M |
|
690
DXP Enterprises
DXPE
$2.98B
| $1.74M | 0.01% |
+18,344
| New | +$1.85M |
|
691
Safe Bulkers
SB
$774M
| $1.74M | 0.01% |
182,721
+97,371
| +114% | +$967K |
|
|
MZTI
692
The Marzetti Company
MZTI
$3.11B
| $1.74M | 0.01% |
+17,464
| New | +$1.57M |
|
693
T. Rowe Price
TROW
$24.3B
| $1.73M | 0.01% |
20,961
+11,784
| +128% | +$955K |
|
|
CRESY
694
Cresud
CRESY
$773M
| $1.72M | 0.01% |
210,323
| – | – |
|
|
LGF
695
DELISTED
Lions Gate Entertainment
LGF
| $1.69M | 0.01% |
+63,270
| New | +$1.94M |
|
696
MaxLinear
MXL
$6.8B
| $1.68M | 0.01% |
177,344
+126,967
| +252% | +$1.27M |
|
|
DST
697
DELISTED
DST Systems Inc.
DST
| $1.68M | 0.01% |
+35,374
| New | +$1.65M |
|
|
ALR
698
DELISTED
AlerisLife Inc
ALR
| $1.68M | 0.01% |
34,471
+3,437
| +11% | +$195K |
|
|
BEAT
699
DELISTED
BioTelemetry, Inc.
BEAT
| $1.66M | 0.01% |
164,937
-14,200
| -8% | -$131K |
|
|
SPNC
700
DELISTED
Spectranetics Corp
SPNC
| $1.66M | 0.01% |
+54,682
| New | +$1.5M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2014 Portfolio in Review
As of Q1 2014, Arrowstreet Capital held 1,547 positions worth $16.5B, down 10% from $18.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Arrowstreet Capital withdrew a net $2.26B in Q1 2014, closing 426 positions and reducing 319 holdings. Its most notable exit was GE Aerospace, an estimated $151M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Arrowstreet Capital opened a new position in Philip Morris worth $192M.
- Arrowstreet Capital's largest Q1 2014 buy was Philip Morris: 2,344,576 shares worth $192M.
- Arrowstreet Capital added most to GSK in Q1 2014, an estimated $233M increase.
- Arrowstreet Capital's biggest Q1 2014 reduction was Vodafone, cutting an estimated $396M.
- Arrowstreet Capital fully exited GE Aerospace in Q1 2014, selling an estimated $151M.
- Arrowstreet Capital's ten largest holdings make up 16% of its $16.5B portfolio in Q1 2014.
- Arrowstreet Capital opened 416 new positions and closed 426 in Q1 2014.
- Arrowstreet Capital's portfolio value fell 10% quarter-over-quarter to $16.5B.
Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.